Literature DB >> 11296144

Human papillomaviruses and cervical cancer in Bangkok. II. Risk factors for in situ and invasive squamous cell cervical carcinomas.

D B Thomas1, Q Qin, J Kuypers, N Kiviat, R L Ashley, A Koetsawang, R M Ray, S Koetsawang.   

Abstract

To identify risk factors for progression of intraepithelial cervical lesions, 190 women with invasive cervical cancer were compared with 75 women with in situ disease diagnosed in Bangkok, Thailand, between September 1991 and September 1993. Polymerase chain reaction-based assays for type-specific human papillomavirus (HPV) DNA in cervical scrapings revealed oncogenic types in 79% of invasive and 57% of intraepithelial tumors. Types 16 and 18, but not types 31/33/35/39, were more common in invasive than intraepithelial tumors, and untyped HPV DNA was found more commonly in the in situ lesions, suggesting that in situ disease is four times more likely to become invasive if due to type 16 or 18 than to other causes, and that tumors with only untyped HPV are not at increased risk of progression. After controlling for HPV type, the risk of developing invasive diseases, compared with the risk of developing intraepithelial lesions, was not related to any of a large number of sexual and hormonal factors considered or to smoking, suggesting that any cofactors these variables represent act before the development of in situ carcinoma. Two indices of socioeconomic status were associated with a reduced risk of only invasive disease, suggesting the existence of unknown protective factors that operate after intraepithelial lesions develop.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11296144     DOI: 10.1093/aje/153.8.732

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  11 in total

1.  Cervical cancer and CYP2E1 polymorphisms: implications for molecular epidemiology.

Authors:  Paula M Ferreira; Raquel Catarino; Deolinda Pereira; Ana Matos; Daniela Pinto; Ana Coelho; Carlos Lopes; Rui Medeiros
Journal:  Eur J Clin Pharmacol       Date:  2005-12-22       Impact factor: 2.953

2.  Efficacy of a real time optoelectronic device (TruScreen™) in detecting cervical intraepithelial pathologies: a prospective observational study.

Authors:  Emre Özgü; Yunus Yıldız; Burçin Salman Özgü; Murat Öz; Nuri Danışman; Tayfun Güngör
Journal:  J Turk Ger Gynecol Assoc       Date:  2015-03-01

Review 3.  The causal relation between human papillomavirus and cervical cancer.

Authors:  F X Bosch; A Lorincz; N Muñoz; C J L M Meijer; K V Shah
Journal:  J Clin Pathol       Date:  2002-04       Impact factor: 3.411

4.  Invited commentary: Human papillomavirus infection and risk of cervical precancer--using the right methods to answer the right questions.

Authors:  Eduardo L Franco; Joseph Tota
Journal:  Am J Epidemiol       Date:  2009-12-10       Impact factor: 4.897

5.  Prevalence of human papillomavirus in university young women.

Authors:  Maria T Montalvo; Ismelda Lobato; Hilda Villanueva; Celia Borquez; Daniela Navarrete; Juan Abarca; Gloria M Calaf
Journal:  Oncol Lett       Date:  2011-04-06       Impact factor: 2.967

6.  Tubal ligation frequency in Oklahoma women with cervical cancer.

Authors:  Cara A Mathews; Julie A Stoner; Nicolas Wentzensen; Katherine M Moxley; Meaghan E Tenney; Erin R Tuller; Tashanna Myers; Lisa M Landrum; Grainger Lanneau; Rosemary E Zuna; Michael A Gold; Sophia S Wang; Joan L Walker
Journal:  Gynecol Oncol       Date:  2012-07-31       Impact factor: 5.482

7.  HPV types, HIV and invasive cervical carcinoma risk in Kampala, Uganda: a case-control study.

Authors:  Michael Odida; Sven Sandin; Florence Mirembe; Bernhard Kleter; Wim Quint; Elisabete Weiderpass
Journal:  Infect Agent Cancer       Date:  2011-06-25       Impact factor: 2.965

8.  Childhood indicators of susceptibility to subsequent cervical cancer.

Authors:  S M Montgomery; A G C Ehlin; P Sparén; B Björkstén; A Ekbom
Journal:  Br J Cancer       Date:  2002-10-21       Impact factor: 7.640

9.  Human papillomavirus infection: an anonymous prevalence study in South Wales, UK.

Authors:  S Hibbitts; G C Rieck; K Hart; N G Powell; R Beukenholdt; N Dallimore; J McRea; A Hauke; A Tristram; A N Fiander
Journal:  Br J Cancer       Date:  2006-07-04       Impact factor: 7.640

10.  Cervical cancer prevention in Indonesia: An updated clinical impact, cost-effectiveness and budget impact analysis.

Authors:  Didik Setiawan; Sri Rezeki Hadinegoro; Hashta Meyta; R Vensya Sitohang; Gertrudis Tandy; Dyah Aryani Perwitasari; Maarten J Postma
Journal:  PLoS One       Date:  2020-03-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.